Fidelity Investments’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $547K | Buy |
158,179
+115,164
| +268% | +$398K | ﹤0.01% | 2929 |
|
|
2025
Q1 | $113K | Sell |
43,015
-53,667
| -56% | -$141K | ﹤0.01% | 3503 |
|
|
2024
Q4 | $398K | Buy |
96,682
+6,910
| +8% | +$28.5K | ﹤0.01% | 3012 |
|
|
2024
Q3 | $636K | Buy |
89,772
+19,296
| +27% | +$137K | ﹤0.01% | 2757 |
|
|
2024
Q2 | $460K | Sell |
70,476
-1,015,613
| -94% | -$6.62M | ﹤0.01% | 2763 |
|
|
2024
Q1 | $9.01M | Sell |
1,086,089
-368,854
| -25% | -$3.06M | ﹤0.01% | 1900 |
|
|
2023
Q4 | $16M | Sell |
1,454,943
-652,790
| -31% | -$7.19M | ﹤0.01% | 1700 |
|
|
2023
Q3 | $17.7M | Sell |
2,107,733
-848,488
| -29% | -$7.14M | ﹤0.01% | 1631 |
|
|
2023
Q2 | $37.1M | Sell |
2,956,221
-5,850,770
| -66% | -$73.5M | ﹤0.01% | 1381 |
|
|
2023
Q1 | $145M | Sell |
8,806,991
-926,857
| -10% | -$15.3M | 0.01% | 851 |
|
|
2022
Q4 | $145M | Sell |
9,733,848
-2,224,364
| -19% | -$33.2M | 0.01% | 819 |
|
|
2022
Q3 | $268M | Sell |
11,958,212
-1,376,843
| -10% | -$30.8M | 0.03% | 568 |
|
|
2022
Q2 | $223M | Sell |
13,335,055
-2,906,951
| -18% | -$48.7M | 0.02% | 647 |
|
|
2022
Q1 | $486M | Buy |
16,242,006
+35,405
| +0.2% | +$1.06M | 0.04% | 450 |
|
|
2021
Q4 | $498M | Buy |
16,206,601
+2,519,797
| +18% | +$77.4M | 0.04% | 457 |
|
|
2021
Q3 | $432M | Buy |
13,686,804
+3,324,804
| +32% | +$105M | 0.03% | 487 |
|
|
2021
Q2 | $379M | Buy |
10,362,000
+4,533,548
| +78% | +$166M | 0.03% | 548 |
|
|
2021
Q1 | $201M | Buy |
5,828,452
+1,066,214
| +22% | +$36.9M | 0.02% | 785 |
|
|
2020
Q4 | $198M | Sell |
4,762,238
-53,641
| -1% | -$2.23M | 0.02% | 750 |
|
|
2020
Q3 | $205M | Buy |
+4,815,879
| New | +$205M | 0.02% | 627 |
|